Max Robotics — Global Service Robot Directory + US Certification

About

Carlo Bergamini is a leading figure in minimally invasive endocrine and oncologic surgery, with a particular focus on adrenal and colorectal procedures. His research has profoundly shaped the surgical management of adrenal disorders, including pheochromocytoma and adrenocortical carcinoma. Bergamini’s landmark works, such as his 2017 study on adrenalectomy indications (50 citations) and a large international multicenter experience comparing robotic and laparoscopic adrenalectomy (41 citations), have provided critical evidence for perioperative outcomes and technique selection. He has also systematically evaluated the comparative effectiveness of robotic versus laparoscopic approaches, notably through a 2025 meta-analysis on pheochromocytoma, helping to clarify ongoing controversies in the field. Beyond adrenal surgery, Bergamini explores the frontiers of surgical innovation, including the role of minimally invasive techniques for locally advanced rectal cancer and the conceptual integration of the metaverse into surgical practice. With a cumulative citation impact exceeding 110, his work is widely referenced by surgeons and researchers seeking to optimize patient outcomes through evidence-based, technology-driven approaches. Bergamini’s contributions continue to define best practices in adrenal and colorectal surgery.